EUVIMEDEUVIMED entdecken
Crossref

Delta-9-tetrahydrocannabutol (Δ9-THCB), Delta-9-tetrahydrocannabihexol (Δ9-THCH), and Delta-9-tetrahydrocannabiphorol (Δ9-THCP): the Impact of Varying Alkyl Chain Length on Delta-9-tetrahydrocannabinol (Δ9-THC) Analog Metabolism

K. James

VCU Scholars Compass (Virginia Commonwealth University) · 21.08.2026

DOI: 10.25772/nqyy-0f17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift VCU Scholars Compass (Virginia Commonwealth University), erschienen am 21.08.2026. Verfasst von K. James.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing availability of delta-9-tetrahydrocannabinol (Δ9-THC) analogs including Δ9 tetrahydrocannabutol (Δ9-THCB), Δ9-tetrahydrocannabihexol (Δ9-THCH), and Δ9 tetrahydrocannabiphorol (Δ9-THCP) in unregulated products has raised questions about the impact of alkyl sidechain length not only on potency, but on metabolism. Δ9-THC homologs were metabolized in vitro with human liver microsomes, and multiple time points were collected. Multiple reaction monitoring (MRM) and precursor ion (PI) scanning methods presumptively identified that Δ9-THCB, Δ9-THCH, and Δ9-THCP produced hydroxylated and carboxylated phase I biomarkers, similar to those of Δ9-THC. The use of universal product ions containing a common core highlights their potential to assist laboratories in future identification of novel Δ9 THC analogs. One carbon deviation in alkyl sidechain length resulted in a decreased formation of the hydroxylated biomarker; whereas two carbon deviations further decreased the amount produced. Although the metabolism rate of the hydroxylated biomarkers was reduced, any deviation from the five-carbon sidechain increased the conversion from the hydroxylated biomarker to the carboxylated biomarker by the cytochrome P450 enzymes. Presumptive identification of novel THC analog metabolites provides new analytical targets for toxicology laboratories seeking the causative agent(s) in cases of suspected intoxication and/or drug toxicity. By understanding the metabolism of novel THC analogs, critical information can then be provided to the public regarding the potential risks of these mass-produced products.

Schlagwörter

alkyl chain lengthdrug metabolismhydroxylated metabolitescytochrome P450human liver microsomesmetabolite identificationtoxicology

Zitieren

APA

James, K. (2026). Delta-9-tetrahydrocannabutol (Δ9-THCB), Delta-9-tetrahydrocannabihexol (Δ9-THCH), and Delta-9-tetrahydrocannabiphorol (Δ9-THCP): the Impact of Varying Alkyl Chain Length on Delta-9-tetrahydrocannabinol (Δ9-THC) Analog Metabolism. VCU Scholars Compass (Virginia Commonwealth University). https://doi.org/10.25772/nqyy-0f17

Vancouver

James K. Delta-9-tetrahydrocannabutol (Δ9-THCB), Delta-9-tetrahydrocannabihexol (Δ9-THCH), and Delta-9-tetrahydrocannabiphorol (Δ9-THCP): the Impact of Varying Alkyl Chain Length on Delta-9-tetrahydrocannabinol (Δ9-THC) Analog Metabolism. VCU Scholars Compass (Virginia Commonwealth University). 2026. doi:10.25772/nqyy-0f17

BibTeX
@article{James2026,
  author = {James, K.},
  title = {Delta-9-tetrahydrocannabutol (Δ9-THCB), Delta-9-tetrahydrocannabihexol (Δ9-THCH), and Delta-9-tetrahydrocannabiphorol (Δ9-THCP): the Impact of Varying Alkyl Chain Length on Delta-9-tetrahydrocannabinol (Δ9-THC) Analog Metabolism},
  journal = {VCU Scholars Compass (Virginia Commonwealth University)},
  year = {2026},
  doi = {10.25772/nqyy-0f17}
}
Kostenlos starten →